Personalized Medicine, Availability, and Group Disparity: An Inquiry into How Physicians Perceive and Rate the Elements and Barriers of Personalized Medicine

被引:16
|
作者
Petersen, Katelin E. [1 ,2 ]
Prows, Cynthia A. [2 ,3 ]
Martin, Lisa J. [1 ,2 ]
Maglo, Koffi N. [4 ,5 ]
机构
[1] Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH 45221 USA
[2] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA
[3] Cincinnati Childrens Hosp Med Ctr, Patient Serv, Cincinnati, OH 45229 USA
[4] Univ Cincinnati, Dept Philosophy, Cincinnati, OH 45221 USA
[5] Univ Cincinnati, CCTST, Cincinnati, OH 45221 USA
关键词
Genetic testing; Health equality; Individualized healthcare; Perceptions; Personalized medicine; Pharmacogenomics; Race; GENOMIC MEDICINE; AFRICAN-AMERICAN; RESPONSE RATES; WARFARIN; RACE; PHARMACOGENETICS; DISEASE; HEALTH; CYP2C9; CARE;
D O I
10.1159/000362359
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The success of personalized medicine depends on factors influencing the availability and implementation of its new tools to individualize clinical care. However, little is known about physicians' views of the availability of personalized medicine across racial/ethnic groups and the relationship between perceived availability and clinical implementation. This study examines physicians' perceptions of key elements/tools and potential barriers to personalized medicine in connection with their perceptions of the availability of the latter across subpopulations. Methods: Study subjects consisted of physicians recruited from Cincinnati Children's Hospital Medical Center and UC Health. An electronic survey conducted from September 2012 to November 2012 recruited 104 physicians. Wilcoxon rank sum analysis compared groups. Results: Physicians were divided about whether personalized medicine contributes to health equality, as 37.4% of them believe that personalized medicine is currently available only for some subpopulations. They also rated the importance of racial/ethnic background almost as high as the importance of genetic information in the delivery of personalized medicine. Actual elements of personalized medicine rated highest include family history, drug-drug interaction alerts in medical records, and biomarker measurements to guide therapy. Costs of gene-based therapies and genetic testing were rated the most significant barriers. The ratings of several elements and barriers were associated with perceived availability of personalized medicine across subpopulations. Conclusion: While physicians hold differing views about the availability and implementation of personalized medicine, they likewise establish complex relationships between race/ethnicity and personalized medicine that may carry serious implications for its clinical success. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:209 / 220
页数:12
相关论文
共 41 条
  • [1] Essential elements of personalized medicine
    Burke, Wylie
    Trinidad, Susan Brown
    Press, Nancy A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (02) : 193 - 197
  • [2] Personalized Medicine: Potential, Barriers and Contemporary Issues
    Sorich, Michael J.
    McKinnon, Ross A.
    CURRENT DRUG METABOLISM, 2012, 13 (07) : 1000 - 1006
  • [3] Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions
    Klein, Michelle E.
    Parvez, Md Masud
    Shin, Jae-Gook
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2368 - 2379
  • [4] Barriers for integrating personalized medicine into clinical practice: A qualitative analysis
    Najafzadeh, Mehdi
    Davis, Jennifer C.
    Joshi, Pamela
    Marra, Carlo
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161A (04) : 758 - 763
  • [5] Personalized medicine in bipolar disorder: how can we overcome the barriers to clinical translation?
    Squassina, Alessio
    Pisanu, Claudia
    PERSONALIZED MEDICINE, 2013, 10 (08) : 765 - 768
  • [6] How advances in personalized medicine will change rheumatology
    Selmi, Carlo
    Kon, Elizaveta
    De Santis, Maria
    Favalli, Ennio G.
    Cimaz, Rolando
    Generali, Elena
    Sinigaglia, Luigi
    PERSONALIZED MEDICINE, 2018, 15 (02) : 75 - 78
  • [7] Personalized Critical Care Medicine: How Far Away Are We?
    Ahasic, Amy M.
    Christiani, David C.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (06) : 809 - 822
  • [8] How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics
    Jones, David S.
    JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES, 2013, 68 (01) : 1 - 48
  • [9] Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment
    Najafzadeh, Mehdi
    Lynd, Larry D.
    Davis, Jennifer C.
    Bryan, Stirling
    Anis, Aslam
    Marra, Marco
    Marra, Carlo A.
    GENETICS IN MEDICINE, 2012, 14 (05) : 520 - 526
  • [10] Personalized Medicine in Neurodegenerative Diseases: How Far Away?
    Kristina Gotovac
    Sanja Hajnšek
    Marija Bošnjak Pašić
    Nela Pivac
    Fran Borovečki
    Molecular Diagnosis & Therapy, 2014, 18 : 17 - 24